retatrutide que es Retatrutide: Reprogramando el metabolismo y liderando la próxima generación de terapias multisistémicas – Espacio Químico – Radar Pharma Retatrutide + Pharma tirzepatide GLP1

That is important, because obesity treatment is not just about the number on the scales

Phase 2 Side-Effect Frequencies at 4.5 mg/week (Lancet 2021) Side Effect Nausea Incidence at 4.5 mg/week 47% Side Effect Injection-site reactions Incidence at 4.5 mg/week 43% Side Effect Constipation Incidence at 4.5 mg/week 21% Side Effect Fatigue Incidence at 4.5 mg/week 20% Side Effect Allergic reactions (any) Incidence at 4.5 mg/week 10% Side Effect Vomiting Incidence at 4.5 mg/week 8% Side Effect Loose stools Incidence at 4.5 mg/week 7% Side Effect Headache Incidence at 4.5 mg/week 7% Side Effect Indigestion Incidence at 4.5 mg/week 4% Incidence was lower at lower doses

These include AAs (branched-chain AAs, Phe, and Tyr), and triglyceride species characterized by lower carbon number and double bond content (14)

Some of these will be mild, like flatulence, cramping, or constipation, whilst others can be more severe